Clinical Trials Browser

Interventional × Liver Failure × sacituzumab govitecan × Clear all

NCT04617522 2026-06-02

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Phase 1 Recruiting

Neoplasm Metastasis, Liver Failure